v3.26.3
Condensed Consolidated Statements of Stockholders' Investment - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2026
Jun. 30, 2026
Mar. 31, 2026
Sep. 30, 2025
Jun. 30, 2025
Mar. 31, 2025
Sep. 30, 2026
Sep. 30, 2025
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Beginning balance (in shares)     118,429       118,429  
Beginning balance $ 1,627,690 $ 1,704,121 $ 1,845,647 $ 1,784,387 $ 1,734,725 $ 1,722,051 $ 1,845,647 $ 1,722,051
Net income 198,469 186,786 147,233 162,987 152,471 135,302 $ 532,488 450,760
Foreign currency adjustments 2,328 399 (431) (2,772) 28,085 10,435    
Dividends declared (74,739) (75,485) (74,887) (75,456) (75,702) (74,418)    
Stock issued for employee benefit plans 2,815 8,586 (27,718) 81,657 5,458 (33,021)    
Stock-based compensation expense 27,782 24,710 28,295 18,746 20,882 23,146    
Repurchase of common stock $ (204,957) (221,427) (214,018) (112,508) (81,532) (48,770)    
Ending balance (in shares) 115,937           115,937  
Ending balance $ 1,579,388 $ 1,627,690 $ 1,704,121 $ 1,857,041 $ 1,784,387 $ 1,734,725 $ 1,579,388 $ 1,857,041
Common Stock                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Beginning balance (in shares) 117,113 118,157 118,429 118,317 118,958 118,664 118,429 118,664
Beginning balance $ 11,711 $ 11,816 $ 11,843 $ 11,832 $ 11,896 $ 11,866 $ 11,843 $ 11,866
Stock issued for employee benefit plans (in shares) 104 222 959 1,062 229 779    
Stock issued for employee benefit plans $ 11 $ 22 $ 96 $ 106 $ 23 $ 78    
Repurchase of common stock (in shares) (1,280) (1,266) (1,231) (958) (870) (485)    
Repurchase of common stock $ (128) $ (127) $ (123) $ (96) $ (87) $ (48)    
Ending balance (in shares) 115,937 117,113 118,157 118,421 118,317 118,958 115,937 118,421
Ending balance $ 11,594 $ 11,711 $ 11,816 $ 11,842 $ 11,832 $ 11,896 $ 11,594 $ 11,842
Additional Paid-in Capital                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Beginning balance 710,902 692,567 734,261 724,076 715,021 775,054 734,261 775,054
Stock issued for employee benefit plans (2,538) (6,375) (69,989) (816) (11,827) (83,179)    
Stock-based compensation expense 27,782 24,710 28,295 18,746 20,882 23,146    
Ending balance 736,146 710,902 692,567 742,006 724,076 715,021 736,146 742,006
Retained Earnings                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Beginning balance 6,254,765 6,143,464 6,071,118 5,923,990 5,847,221 5,786,337 6,071,118 5,786,337
Net income 198,469 186,786 147,233 162,987 152,471 135,302    
Dividends declared (74,739) (75,485) (74,887) (75,456) (75,702) (74,418)    
Ending balance 6,378,495 6,254,765 6,143,464 6,011,521 5,923,990 5,847,221 6,378,495 6,011,521
Accumulated Other Comprehensive Loss                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Beginning balance (77,706) (78,105) (77,674) (71,882) (99,967) (110,402) (77,674) (110,402)
Foreign currency adjustments 2,328 399 (431) (2,772) 28,085 10,435    
Ending balance (75,378) (77,706) (78,105) (74,654) (71,882) (99,967) (75,378) (74,654)
Treasury Stock                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Beginning balance (5,271,982) (5,065,621) (4,893,901) (4,803,629) (4,739,446) (4,740,804) (4,893,901) (4,740,804)
Stock issued for employee benefit plans 5,342 14,939 42,175 82,367 17,262 50,080    
Repurchase of common stock (204,829) (221,300) (213,895) (112,412) (81,445) (48,722)    
Ending balance $ (5,471,469) $ (5,271,982) $ (5,065,621) $ (4,833,674) $ (4,803,629) $ (4,739,446) $ (5,471,469) $ (4,833,674)